Celcuity: A Beacon of Hope in the Fight Against Breast Cancer

Celcuity is a US biotechnology company focused on developing targeted therapies for cancer. The emphasis is on identifying new disease mechanisms in tumor cells to enable personalized treatment approaches. With its proprietary CELsignia platform, Celcuity investigates signaling pathways in living tumor cells in real-time, identifying patient groups that respond particularly well to specific compounds. The breast cancer program with the compound Gedatolisib is particularly advanced and is being tested in clinical trials, potentially expanding the...